Peripheral Neuropathy Treatment Market, by Type (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and Others), by Treatment (Pharmacological Therapies (Pain Relievers, Anti-seizure Medications,

Peripheral Neuropathy Treatment Market, by Type (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and Others), by Treatment (Pharmacological Therapies (Pain Relievers, Anti-seizure Medications, and Antidepressants) and Non-pharmacological Therapies (Transcutaneous Electrical Nerve Stimulation, Plasma Exchange and Intravenous Immune Globulin, and Others), by Distribution Channel (Hospitals and Clinics, Ambulatory Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Peripheral neuropathy is a disorder that affects the peripheral nerves. Peripheral neuropathy has a variety of systemic, metabolic, and toxic causes, for instance diabetes in metabolic cause. The most common treatable causes include diabetes mellitus, hypothyroidism, and nutritional deficiencies. The diagnosis require careful clinical assessment, judicious laboratory testing, and electro diagnostic studies or nerve biopsy, if the diagnosis remains unclear.

Market Dynamics

Rising aging population is expected to drive the global peripheral neuropathy treatment market growth. For instance, according to an article published by the World Health Organization (WHO) in February 2018, reports that between 2015 and 2050, the proportion of the worldwide geriatric population will nearly double from 12% to 22%.

Moreover, rising diabetic cases is expected to drive the market growth. For instance, according to an article published by the International Diabetes Federation (IDF), in 2017, the estimated number of 18 to 99 year old diabetic patients was around 425 million globally.

researched

medicinal properties of cannabis and its derivatives are widely

Researched

Medicinal properties of cannabis and its derivatives are widely

researched

medicinal properties of cannabis and its derivatives are widely

researched

medicinal properties of cannabis and its derivatives are widely

researched

Key features of the study:

  • This report provides in-depth analysis of the global peripheral neuropathy treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global peripheral neuropathy treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Abbott, Bristol Myers Squibb, Cipla Limited, Eli Lilly and Company, GlaxoSmithKline plc., Lupin Limited, Merck and Co. Inc., Novartis AG, Pfizer Inc., Dr. Reddy's Laboratories, Mylan NV, Johnson & Johnson Services Inc., and Teva Pharmaceutical Industries Ltd, among others.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global peripheral neuropathy treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral neuropathy treatment market.
Detailed Segmentation:
  • Global Peripheral Neuropathy Treatment Market, By Type:
  • Diabetic Peripheral Neuropathy
  • Chemotherapy-induced Peripheral Neuropathy
  • Idiopathic Peripheral Neuropathy
  • Others
  • Global Peripheral Neuropathy Treatment Market, By Treatment:
  • Pharmacological Therapies
  • Pain Relievers
  • Anti-seizure Medications
  • Antidepressants
  • Non-pharmacological Therapies
  • Transcutaneous Electrical Nerve Stimulation
  • Plasma Exchange and Intravenous Immune Globulin
  • Others
  • Global Peripheral Neuropathy Treatment Market, By Distribution Channel:
  • Hospitals and Clinics
  • Ambulatory Centers
  • Others
  • Global Peripheral Neuropathy Treatment Market, By Region:
  • North America
  • By Type:
  • Diabetic Peripheral Neuropathy
  • Chemotherapy-induced Peripheral Neuropathy
  • Idiopathic Peripheral Neuropathy
  • Others
  • By Treatment:
  • Pharmacological Therapies
  • Pain Relievers
  • Anti-seizure Medications
  • Antidepressants
  • Non-pharmacological Therapies
  • Transcutaneous Electrical Nerve Stimulation
  • Plasma Exchange and Intravenous Immune Globulin
  • Others
  • By Distribution Channel:
  • Hospitals and Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Type:
  • Diabetic Peripheral Neuropathy
  • Chemotherapy-induced Peripheral Neuropathy
  • Idiopathic Peripheral Neuropathy
  • Others
  • By Treatment:
  • By Treatment:
  • Pharmacological Therapies
  • Pain Relievers
  • Anti-seizure Medications
  • Antidepressants
  • Non-pharmacological Therapies
  • Transcutaneous Electrical Nerve Stimulation
  • Plasma Exchange and Intravenous Immune Globulin
  • Others
  • By Distribution Channel:
  • Hospitals and Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Type:
  • Diabetic Peripheral Neuropathy
  • Chemotherapy-induced Peripheral Neuropathy
  • Idiopathic Peripheral Neuropathy
  • Others
  • By Treatment:
  • Pharmacological Therapies
  • Pain Relievers
  • Anti-seizure Medications
  • Antidepressants
  • Non-pharmacological Therapies
  • Transcutaneous Electrical Nerve Stimulation
  • Plasma Exchange and Intravenous Immune Globulin
  • Others
  • By Distribution Channel:
  • Hospitals and Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Type:
  • Diabetic Peripheral Neuropathy
  • Chemotherapy-induced Peripheral Neuropathy
  • Idiopathic Peripheral Neuropathy
  • Others
  • By Treatment:
  • Pharmacological Therapies
  • Pain Relievers
  • Anti-seizure Medications
  • Antidepressants
  • Non-pharmacological Therapies
  • Transcutaneous Electrical Nerve Stimulation
  • Plasma Exchange and Intravenous Immune Globulin
  • Others
  • By Distribution Channel:
  • Hospitals and Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Type:
  • Diabetic Peripheral Neuropathy
  • Chemotherapy-induced Peripheral Neuropathy
  • Idiopathic Peripheral Neuropathy
  • Others
  • By Treatment:
  • Pharmacological Therapies
  • Pain Relievers
  • Anti-seizure Medications
  • Antidepressants
  • Non-pharmacological Therapies
  • Transcutaneous Electrical Nerve Stimulation
  • Plasma Exchange and Intravenous Immune Globulin
  • Others
  • By Distribution Channel:
  • Hospitals and Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Type:
  • Diabetic Peripheral Neuropathy
  • Chemotherapy-induced Peripheral Neuropathy
  • Idiopathic Peripheral Neuropathy
  • Others
  • By Treatment:
  • Pharmacological Therapies
  • Pain Relievers
  • Anti-seizure Medications
  • Antidepressants
  • Non-pharmacological Therapies
  • Transcutaneous Electrical Nerve Stimulation
  • Plasma Exchange and Intravenous Immune Globulin
  • Others
  • By Distribution Channel:
  • Hospitals and Clinics
  • Ambulatory Centers
  • Others
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Abbott*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Bristol Myers Squibb
  • Cipla Limited
  • Eli Lilly and Company
  • GlaxoSmithKline plc.
  • Lupin Limited
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Dr. Reddy's Laboratories
  • Mylan NV
  • Johnson & Johnson Services Inc.
  • Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Market Snippet, By Treatment
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis
Reimbursement Scenario
Epidemiology
Pest Analysis
Regulatory Scenario
New Product Launches
Collaborations and Agreements
Market Trends
4. Global Peripheral Neuropathy Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Market Scenario
Impact of COVID-19 Market on the Peripheral Neuropathy Treatment Products
5. Global Peripheral Neuropathy Treatment Market, By Type, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Diabetic Peripheral Neuropathy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Chemotherapy-induced Peripheral Neuropathy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Idiopathic Peripheral Neuropathy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
6. Global Peripheral Neuropathy Treatment Market, By Treatment, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Pharmacological Therapies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Pain Relievers
Anti-seizure Medications
Antidepressants
Non-pharmacological Therapies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Transcutaneous Electrical Nerve Stimulation
Plasma Exchange and Intravenous Immune Globulin
Others
7. Global Peripheral Neuropathy Treatment Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Ambulatory Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
8. Global Peripheral Neuropathy Treatment Market, By Region, 2016 – 2027, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2020 and 2027 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2027
North America
Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
South Africa
Central Africa
North Africa
9. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Abbott
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol Myers Squibb
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Cipla Limited
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Eli Lilly and Company
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
GlaxoSmithKline plc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Lupin Limited
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck and Co. Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Novartis AG
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Dr. Reddy's Laboratories
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Mylan NV
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson & Johnson Services Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
10. Analyst Views
11. Section
References
Research Methodology
About us and Sales Contact
*Browse 48 market data tables and 340figures on "Peripheral Neuropathy Treatment Market” - Global forecast to 2027

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook